The 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and 5th New Investment Conference (hereinafter referred to as '2026 Frost & Sullivan Summit' or 'Conference'), organized by Frost & Sullivan, a world-leading growth consulting firm, will be held grandly in Shanghai from August 4-5, 2026. During the conference, a new investment forum on Life Science will be launched. The forum will feature three parallel sessions focusing on biomedicine, medical devices, and health technology, presenting cutting-edge topics and latest insights. With the core concept “Driving Change through Innovation, Staying Resilient and Achieving Long-Term Success”, the forum invites industry leaders, biomedicine and medical device companies, health technology firms, investment institutions, and professional service organizations to deeply discuss emerging trends in life science, innovative technologies, and global development paths, aiming to promote industrial advancement and global collaboration.The ‘Global Brain-Computer Interface Industry White Paper’ will be released during the Medical Devices session of the 5th Life Science New Investment Forum on August 5.
Host City: Shanghai, China
Date: August 4-5, 2026
Conference Scale: 5,000+
Conference Format: Offline + Online Live Streaming
Organizer: Frost & Sullivan
Scan the QR code to register immediately
White Paper Release
The ‘Global Brain-Computer Interface Industry White Paper’ will be released during the Medical Devices session of the 5th Life Science New Investment Forum on August 5.
Currently, innovative achievements in the field of brain-computer interfaces in China continue to emerge, and the industry is developing rapidly, becoming an important area where technological innovation and industrial innovation are deeply integrated. By establishing a full-chain ecosystem of “technical breakthroughs—application scenarios—industrial clustering” and a priority review mechanism, China is accelerating its transition from key technical breakthroughs to global industry leadership, creating new advantages for Chinese enterprises in international competition. In this context, Frost & Sullivan aims to provide a comprehensive analysis of the industry’s development stage, structural characteristics, and evolution path through this white paper, as well as an in-depth examination of the current situation and market potential in key application areas, offering forward-looking market insights and strategic decision-making references for all participants in the industry chain to seize opportunities and address challenges.
Summary of Main Contents of the ‘Global Brain-Computer Interface Industry White Paper’
|
Comprehensive Overview of Brain-Computer Interface Industry Development |
Scope and Evolution:Systematically define the technical definitions of brain-computer interfaces (invasive, semi-invasive, non-invasive), and analyze their evolution from laboratory prototypes to clinical trials.
Core Drivers:Deeply analyze the key factors driving industry development, including breakthroughs in neuroscience basic research, progress in microelectronics and flexible materials, iterative development of decoding algorithms (AI), and policy strategies for future industry development. |
|
Analysis of Key Application Areas and Industrial Chain of Brain-Computer Interfaces |
Medical Rehabilitation:Rehabilitation of motor functions (exoskeletons, prosthetic replacement), language disorder treatment, epilepsy early warning, and spinal cord injury repair.
Intervention in Neuropsychiatric Diseases:Digital therapies such as AI-assisted depression treatment, early screening for Alzheimer’s disease, and autism rehabilitation training.
Non-medical Frontier Applications:Cognitive enhancement (attention training, sleep management), human-machine interaction (metaverse control, industrial assistance), and skill enhancement in special environments. |
|
Global Market Comparison and Business Model Exploration Analysis |
Market Environment Comparison:Comparative analysis of differences between the United States, China, and Europe in ethical review, regulatory standards for implantable devices (such as FDA and NMPA), efficiency of scientific research translation, and ecological maturity.
Business Model Evaluation:Discuss the maturity of transformation from “research equipment sales” to “consumables + services”, “implantable devices”, and “consumer electronics”; analyze differentiated growth strategies for B-side (hospitals/rehabilitation centers) and C-side (general public health) markets. |
|
Analysis of Core Challenges and Future Development Trends in the Brain-Computer Interface Industry |
Key Challenges:Identify and analyze technical bottlenecks faced by the industry (signal attenuation, long-term biocompatibility, privacy risks), algorithm robustness, ethical and legal issues (identity, mental privacy, cognitive sovereignty), and payment mechanisms (medicare coverage).
Future Trends:Analyze the integration directions of BCI and multi-modal AI, brain-like computing, and nanotechnology, and explore potential paths for brain-computer interfaces to evolve into “brain-computer integration” as well as the ecological value of “safe and trustworthy, people-centered”. |
|
Introduction to Brain-Computer Interface Companies |
The white paper will include partner companies, presenting the business areas, product layouts, technical platforms, and differential advantages of upstream and downstream companies in the brain-computer interface industry, highlighting the product features and competitive strengths of each partner company. |
Highlights from Last Conference
Review of Last Forum:Strengthening Foundations, Navigating Waves – The 2025 Frost & Sullivan Life Science New Investment Forum came to a successful conclusion!
More Summit Information Consultation
Life Science New Investment Forum
Event Consultation | Sponsorship Cooperation | Registration Consultation
📞 Conference Consultation Hotline:
021-3209-6800 ext. 8672
📧 Conference Consultation Email:
gil@frostchina.com
